Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study.
Rouamba T, Barry H, Ouédraogo E, Tahita MC, Yaméogo NV, Poda A, Diendéré AE, Ouedraogo AS, Valea I, Koné AM, Thiombiano C, Traoré I, Tarnagda Z, Sawadogo SA, Gansané Z, Kambiré Y, Sanou I, Barro-Traoré F, Drabo MK, Tinto H; CHLORAZ Study Group.
Rouamba T, et al. Among authors: drabo mk.
Ther Clin Risk Manag. 2021 Nov 15;17:1187-1198. doi: 10.2147/TCRM.S330813. eCollection 2021.
Ther Clin Risk Manag. 2021.
PMID: 34815671
Free PMC article.